Laurie Myers
Director de Operaciones en CINGULATE INC. .
Fortuna: 2 028 $ al 30/04/2024
Perfil
Laurie A.
Myers is currently the Chief Operating Officer at Cingulate Therapeutics LLC, Chief Operating Officer & Executive Vice President at Cingulate Works, Inc., and Chief Operating Officer & Executive VP at Cingulate, Inc. Previously, she worked as the Head-Marketing at Fidia Pharma USA, Inc. Dr. Myers holds an MBA from St. Joseph's University, undergraduate and graduate degrees from the University of Scranton, and a doctorate from New Jersey Medical School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CINGULATE, INC.
0.06% | 15/04/2024 | 2 414 ( 0.06% ) | 2 028 $ | 30/04/2024 |
Cargos activos de Laurie Myers
| Empresas | Cargo | Inicio |
|---|---|---|
| CINGULATE INC. | Director de Operaciones | 01/04/2017 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Director de Operaciones | 01/11/2017 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Director de Operaciones | 01/04/2017 |
Antiguos cargos conocidos de Laurie Myers.
| Empresas | Cargo | Fin |
|---|---|---|
Fidia Pharma USA, Inc.
 Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946. | Ventas & Marketing | 01/11/2017 |
Formación de Laurie Myers.
| New Jersey Medical School | Doctorate Degree |
| St. Joseph's University | Masters Business Admin |
| University of Scranton | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
Fidia Pharma USA, Inc.
Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946. | Health Technology |
- Bolsa de valores
- Insiders
- Laurie Myers
